ArticleThe Journal of clinical investigation2024

Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers.

Yueming Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.